Yahoo! Finance: NVO News

MannKind Awaits FDA Decision (Zacks.com)

Wed, 6 Jan 2010 20:54:09 Etc/GMT

With no product on the market and no revenues, we are very concerned about MannKind's financial position.

Biotech Stocks: Drug stocks gain; Alcon, Novartis fall on deal (at MarketWatch)

Mon, 4 Jan 2010 18:31:00 Etc/GMT

Drug stocks rise in early action while shares of Swiss healthcare companies Alcon Inc. and Novartis AG fall on news that Novartis was moving to buy the remaining shares of Alcon that it doesn't already own.

Generation Shifts Hit The Leadership Suite (Investor's Business Daily)

Thu, 31 Dec 2009 23:25:36 Etc/GMT

Get ready for the "X" and "Y" factor in management.

Biotech Stocks: Drug stocks slip; Compugen rallies (at MarketWatch)

Wed, 30 Dec 2009 19:02:00 Etc/GMT

Compugen reports it made about $20 million.

Research Update (Marketwire)

Wed, 30 Dec 2009 08:20:00 Etc/GMT

Novo Nordisk awaiting FDA comment on diabetes drug (at MarketWatch)

Wed, 30 Dec 2009 07:53:58 Etc/GMT

Mutual Fund Managers Buy Abroad (at TheStreet.com)

Fri, 18 Dec 2009 10:00:00 Etc/GMT

Why Big Pharmas 2010 Looks Challenging (at Minyanville.com)

Thu, 17 Dec 2009 18:40:00 Etc/GMT

The stagnant economy may finally catch up to it.

Amylin Impresses in Head-to-Head (Zacks.com)

Wed, 16 Dec 2009 21:54:59 Etc/GMT

Exenatide once weekly is currently being reviewed by the U.S. Food and Drug Administration ; a response should be out in the first quarter of 2010.

4-Star Stocks Poised to Pop: Eli Lilly (at Motley Fool)

Wed, 16 Dec 2009 15:09:52 Etc/GMT

Novo CEO Just Says "No" (at CNBC)

Tue, 15 Dec 2009 14:24:27 Etc/GMT

Eli Lillys Prognosis: Uncertainty (at Minyanville.com)

Thu, 10 Dec 2009 18:15:00 Etc/GMT

What happens when a patent cliff is within sight.

Investigating The FCPA (at Forbes.com)

Tue, 8 Dec 2009 18:06:24 Etc/GMT

ZGEN Inks Licensing Deal (Zacks.com)

Tue, 8 Dec 2009 13:02:22 Etc/GMT

Novo Nordisk Licenses IL-21 mAb and Patent Rights to IL-21 Antibodies from ZymoGenetics (Business Wire)

Tue, 8 Dec 2009 07:00:00 Etc/GMT

SEATTLE & COPENHAGEN----Novo Nordisk A/S and ZymoGenetics, Inc. today announced an agreement where Novo Nordisk in-licenses a fully-human anti-IL21 monoclonal antibody developed by ZymoGenetics, as well as broad intellectual property rights covering IL-21 mAb and the development of other IL-21 antibodies.

FDA Approves 10 mcg Dose of Vagifem(R) for the Treatment of Atrophic Vaginitis Due to Menopause (PR Newswire)

Wed, 2 Dec 2009 14:00:00 Etc/GMT

Novo Nordisk said today that the U.S. Food and Drug Administration has approved a 10 mcg dose formulation of Vagifem® for the treatment of atrophic vaginitis due to menopause - a condition experienced by up to 75 percent of postmenopausal women.

Increase In Patent Protection For Biologics Creates Significant Upside For Drug Development Enterprise Valuations (Wall Street Transcript)

Sat, 28 Nov 2009 15:31:00 Etc/GMT

67 WALL STREET, New York - November 28, 2009 - The Wall Street Transcript has recently published its Q4 2009 Biotechnology Report offering a timely review of the sector to serious investors and industry executives. This 70 page feature contains expert industry commentary through in-depth interviews with public company CEOs, Equity Analysts and Money Managers. The full issue is available by calling (212) 952-7433 or via The Wall Street Transcript Online.

Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows (PR Newswire)

Fri, 27 Nov 2009 14:30:00 Etc/GMT

The diabetes population in the United States will almost double over the next 25 years and annual medical spending on the disease is projected to hit $336 billion, up from $113 billion today, according to a study published in the December issue of Diabetes Care.

The Complete List of Danish ADR Stocks (at Seeking Alpha)

Fri, 20 Nov 2009 11:36:09 Etc/GMT

Doctors Cite Time, Low Reimbursement As Barriers To Providing Comprehensive Diabetes Care, Survey Results Show (PR Newswire)

Thu, 19 Nov 2009 13:00:00 Etc/GMT

Equipped to Provide Ideal, Multi-Disciplinary Team Care